Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New model allows assessment of two islet preparations in one primate

June 18, 2012

Multiple insulin degludec trials presented at recent conferences

June 18, 2012

Research underlying BioLineRx project wins award

June 15, 2012

LY-2881835 shows antidiabetic activity in vivo

June 15, 2012

British group divulges new bifunctional agents

June 15, 2012

FDA accepts NDA for Raptor Pharmaceuticals' nephropathic cystinosis drug

June 14, 2012

JDRF and Novo Nordisk establish type 1 diabetes partnership

June 14, 2012

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

June 14, 2012

FDA grants fast track status to synthetic ectodysplasin-A

June 13, 2012

Combination therapy shows surprising synergistic efficacy in Batten disease model

June 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...